Physician profile
Keshav K Deshpande
NPI 1285958611
$58,187.22
in general payments reported to CMS, 2019-2025
9 companies · $11K in 2025
The $11K reported for 2025 was more than what 97% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $10.68 · 2022: $16K · 2023: $7,287 · 2024: $24K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $24K · Consulting Fee: $12K · Education: $3,000 · Food and Beverage: $2,169 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,700 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $23,942.54 |
| Consulting Fee | $11,680.00 |
| Education | $3,000.00 |
| Food and Beverage | $2,169.06 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,700.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $51,610.91 | 2022-2025 | Teg6s Hemostasis System, Teg Manager |
| Intuitive Surgical, INC. | $5,971.77 | 2022-2024 | Da Vinci Surgical System |
| Prytime Medical Devices, INC. | $176.36 | 2019-2022 | |
| Innovation Technologies INC | $145.30 | 2025 | Irrisept |
| Csl Behring | $96.96 | 2025 | Kcentra |
| Smith+Nephew, INC. | $81.88 | 2022 | |
| Medical Device Business Services, INC. | $50.69 | 2025 | |
| Abbvie INC. | $34.65 | 2024 | |
| Ethicon US, LLC | $18.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keshav Deshpande listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.